Granisetron Tablet Manufacturer | Exporter and Global Supplier in India

Granisetron Tablet Manufacturer, as a trusted we produce high-quality, safe, and reliable tablets that adhere to WHO-GMP standards, ensuring consistent efficacy and patient safety for hospitals, clinics, and healthcare distributors globally. Granisetron Tablet is a highly effective pharmaceutical formulation designed to prevent and manage nausea and vomiting associated with chemotherapy, radiotherapy, and post-operative conditions.

About Granisetron Tablet

Granisetron belongs to the class of 5-HT3 receptor antagonists. It works by blocking serotonin receptors both in the central nervous system and the gastrointestinal tract, which are primarily responsible for triggering nausea and vomiting. Our Granisetron Tablet Manufacturer ensures that each tablet contains precise dosages to provide rapid and effective relief from emesis while maintaining maximum stability and bioavailability.

Key Benefits and Uses

• Prevention of chemotherapy-induced nausea and vomiting (CINV).

• Management of post-operative nausea and vomiting (PONV).

• Control of radiation-induced nausea and vomiting in cancer patients.

• Easy oral administration for patient convenience and adherence.

• Rapid onset of action with prolonged antiemetic effect.

As a leading Granisetron Tablet Manufacturer, we focus on delivering tablets that are reliable, safe, and effective in improving patient comfort and compliance during cancer treatment or surgical recovery.

Dosage and Administration

Granisetron Tablet is generally taken orally with water, usually once daily or as prescribed by a physician. The exact dosage depends on the patient’s age, body weight, type of chemotherapy, or surgical procedure. Our WHO-GMP certified Granisetron Tablet Manufacturer ensures uniformity in every batch so that patients receive consistent therapeutic benefits with each tablet.

Precautions

• Only use under medical supervision; self-medication is not recommended.

• Inform the healthcare provider about any pre-existing medical conditions such as liver dysfunction, heart disorders, or electrolyte imbalance.

• Pregnant or breastfeeding women should consult a physician before using Granisetron tablets.

• Avoid concurrent use with other 5-HT3 receptor antagonists unless directed by a doctor.

• Monitor for any signs of allergic reaction during the course of treatment.

Being a responsible Granisetron Tablet Manufacturer, we provide guidance on safe usage to maximize efficacy and minimize potential risks.

Possible Side Effects

Although generally well tolerated, some patients may experience mild to moderate side effects, including:

• Headache or dizziness

• Constipation or mild diarrhea

• Fatigue or general weakness

• Flushing or redness

• Rare allergic reactions such as swelling, rash, or difficulty breathing

As a trusted Granisetron Tablet Manufacturer, we emphasize patient safety, monitoring, and adherence to recommended guidelines to minimize side effects while ensuring maximum therapeutic benefit.

Why Choose Us?

• WHO-GMP certified Granisetron Tablet Manufacturer delivering high-quality, safe, and effective tablets.

• Bulk supply and global distribution for hospitals, clinics, and healthcare providers.

• Stringent quality control and adherence to international manufacturing standards.

• Expertise in antiemetic tablet formulations with precise dosing and long shelf life.

Our mission as a leading Granisetron Tablet Manufacturer is to enhance patient care by providing reliable, effective, and premium-quality oral antiemetic solutions that improve comfort, reduce nausea and vomiting, and support adherence to treatment plans in chemotherapy, radiotherapy, and post-operative care.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Granisetron Tablet  to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.